Module Database Search
MODULE DESCRIPTOR | |||
---|---|---|---|
Module Title | |||
Evidence Based Therapeutics | |||
Reference | PL2004 | Version | 1 |
Created | April 2022 | SCQF Level | SCQF 8 |
Approved | June 2022 | SCQF Points | 30 |
Amended | ECTS Points | 15 |
Aims of Module | |||
---|---|---|---|
To develop knowledge of what constitutes evidence base and how its applied in clinical practice. |
Learning Outcomes for Module | |
---|---|
On completion of this module, students are expected to be able to: | |
1 | Explain the concept of what evidence base is and how this informs the development of local and national guidelines. |
2 | Describe appropriate literature search strategies and critically appraise and analyse research articles for their validity and relevance to pharmacy practice. |
3 | Understand the role of ethics and statistics in conducting research studies. |
4 | Explain the differences between different study designs and their application to pharmacoepidemiology. |
Indicative Module Content |
---|
Research methodology, Quantitative and qualitative methods, Health economics, pharmacoepidemiology, Preparing a literature review, Putting research into practice, Principles of research ethics, Antimicrobial Stewardship, Critical Appraisal of medical evidence, Guidelines and development, Introduction to epidemiology, Statistical methods in research, study designs. |
Module Delivery |
---|
Lectures, coursework sessions (including individual and group problem solving exercises and tutorial sessions) and directed study (including computer packages, directed reading, and self-assessment exercises). |
Indicative Student Workload | Full Time | Part Time |
---|---|---|
Contact Hours | 70 | N/A |
Non-Contact Hours | 230 | N/A |
Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
TOTAL | 300 | N/A |
Actual Placement hours for professional, statutory or regulatory body |   |   |
ASSESSMENT PLAN | |||||
---|---|---|---|---|---|
If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
Component 1 | |||||
Type: | Coursework | Weighting: | 100% | Outcomes Assessed: | 1, 2, 3, 4 |
Description: | Production of an evidenced based guideline |
MODULE PERFORMANCE DESCRIPTOR | |
---|---|
Explanatory Text | |
A minimum of grade D or better is required to pass this module. | |
Module Grade | Minimum Requirements to achieve Module Grade: |
A | When the grade for Component 1(CW1) is an A. |
B | When the grade for Component 1(CW1) is an B. |
C | When the grade for Component 1(CW1) is an C. |
D | When the grade for Component 1(CW1) is an D. |
E | When the grade for Component 1(CW1) is an E. |
F | When the grade for Component 1(CW1) is an F. |
NS | Non-submission of work by published deadline or non-attendance for examination |
Module Requirements | |
---|---|
Prerequisites for Module | Successful completion of MPharm Stage 1 or equivalent. |
Corequisites for module | None. |
Precluded Modules | None. |
INDICATIVE BIBLIOGRAPHY | |
---|---|
None. |